Latest news with #Candidaalbicans
Hindustan Times
5 days ago
- Health
- Hindustan Times
Monsoon and gynaecological infections: Gynac shares 5 common types, early warning signs and prevention tips
The increased humidity in the monsoon season acts as a breeding ground for infections. Gynaecological infections also spike during this time. In an interview with HT Lifestyle, Dr. Vinoad Bharrati, director and consultant gynaecologist at Rising Medicare Hospital and Elite Momz, Pune said, 'Sometimes women become compelled to wear such moist undergarments. There's more sweating. All of this causes the intimate area to become more moist and wet, creating a breeding ground for a variety of fungal and bacterial infections.' Also read | Gynaecologist shares 6 tips to reduce the risk of monsoon-related intimate area infections Gynaecological infections spike during monsoon.(Shutterstock) Here are the 5 most common Gynaecological Infections that spike during the monsoon: 1. Vulvovaginal candidiasis: VVC usually is caused by Candida albicans but can occasionally be caused by other Candida species or yeasts. Typical symptoms of VVC include vaginal soreness, external dysuria, and abnormal vaginal discharge. 2. Urinary tract infections: Urinary tract infections (UTIs) are common infections that affect any part of the urinary system, including the kidneys, ureters, bladder, and urethra. Also read | Women's health: Common gynaecological infections, symptoms and treatment 3. Bacterial vaginosis: Bacterial vaginosis (BV) is a common vaginal infection caused by an imbalance of bacteria in the vagina, leading to symptoms like a fishy odour and unusual discharge 4. Pelvic inflammatory disease: Pelvic Inflammatory Disease (PID) is an infection of the female reproductive organs, including the uterus, fallopian tubes, and ovaries. It typically results from an untreated sexually transmitted infection (STI), such as chlamydia or gonorrhoea. 5. Trichomoniasis: Trichomoniasis is a common sexually transmitted infection (STI) caused by the parasite Trichomonas vaginalis. Their symptoms may include burning, itching and unusual discharge. Also read | Gynaecologist shares 9 tips to boost immunity in women during monsoon: 'Add as many spices as possible to your meals' UTI and yeast infections can be very painful.(Pexels) Early warning signs of gynaecological infections: Curdy white discharge. Fowl-smelling discharge Excess itching and discomfort in the intimate area Lower abdominal pain. At times, burning in urine Prevention tips to follow: Use comfortable and cotton inner wear Change inner wear if it is wet Use comfortable and breezy clothes Avoid wearing tight garments Keep intimate area dry Avoid using any fragrance or perfume for intimate area Cleaning the surface before using contaminated public toilets Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Yahoo
29-07-2025
- Health
- Yahoo
Smile Source Partners with SimplyTest to Bring Salivary Screening to 800+ Independent Dental Practices
SimplyTest Oral Health-PERIO gives dentists a new tool for personalized, preventive care SALT LAKE CITY, July 29, 2025--(BUSINESS WIRE)--SimplyTest®, a leader in salivary testing solutions, today announced a strategic partnership with Smile Source, the nation's largest network of independent dental practices, to deliver SimplyTest Oral Health-PERIO, a cutting-edge salivary testing solution, to more than 800 Smile Source member offices. "This partnership reflects a shared mission of our two organizations: to empower dentists with best-in-class tools that improve patient outcomes," said Justin Hunt, CEO of SimplyTest. "Smile Source is known for its high standards and rigorous vendor vetting. We're honored to be selected as their exclusive salivary screening partner, offering members access to PERIO through their trusted membership platform." This is the first salivary testing solution offered through Smile Source, underscoring the growing demand among private practitioners for integrated, preventive health solutions in dentistry. With PERIO, member dentists will be equipped to provide earlier, more precise care and expand their role in systemic health detection and personalized treatment. Periodontal disease doesn't just affect the mouth; it is a chronic, often silent condition with far-reaching consequences including strong links to Alzheimer's, diabetes, cardiovascular disease and cancer. PERIO helps dental professionals uncover what traditional exams may overlook. By detecting microbial risk factors early, clinicians can intervene sooner and educate patients more effectively to better support long-term health. "We're thrilled to welcome SimplyTest Oral Health-PERIO to the Smile Source family," said Tom Rimmer, Vice President of Strategic Partnerships at Smile Source. "This partnership gives our members access to a science-backed, noninvasive testing tool, which many have been asking for to elevate patient care. PERIO represents a meaningful advancement in their clinical capabilities, and we're excited to see its positive impact across the network." PERIO integrates advanced molecular testing into everyday dental workflows. A quick, pain-free saliva sample identifies key periodontal pathogens, caries-related organisms, Candida albicans and viruses associated with cognitive decline, cardiovascular disease and more. A patented buffer solution stabilizes samples at room temperature, making the test easy to implement and practical for busy practices. PERIO represents a shift toward smarter, evidence-based care. For Smile Source members, it not only enhances treatment outcomes at the chair, but also elevates their role as vital contributors to their patients' overall health. About Smile Source Smile Source is the leading network of independent dental practices in the United States, supporting more than 800 independently owned offices with the collective power to compete, grow and thrive. Through access to proven technology, innovative clinical solutions, and shared business resources, Smile Source empowers dentists to elevate patient care, enhance profitability and protect their independence. To learn more, visit About SimplyTest SimplyTest® is redefining the starting point of care through next-generation salivary science. The SimplyTest platform delivers fast, noninvasive screenings that empower health care providers, functional medicine practitioners and dental professionals to detect microbial risks earlier, personalize treatment with precision and connect oral health to whole-body outcomes. Built on the belief that better diagnostics lead to better outcomes, SimplyTest is advancing a smarter, data-driven model of dentistry where early insight is the first step in personalized care. To learn more, visit View source version on Contacts Media Contact: Tim Rush for 801-208-1100 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
29-07-2025
- Health
- Business Wire
Smile Source Partners with SimplyTest to Bring Salivary Screening to 800+ Independent Dental Practices
SALT LAKE CITY--(BUSINESS WIRE)--SimplyTest®, a leader in salivary testing solutions, today announced a strategic partnership with Smile Source, the nation's largest network of independent dental practices, to deliver SimplyTest Oral Health-PERIO, a cutting-edge salivary testing solution, to more than 800 Smile Source member offices. SimplyTest Oral Health-PERIO is the first salivary testing solution offered through Smile Source, underscoring the growing demand among private practitioners for integrated, preventive health solutions in dentistry. Share 'This partnership reflects a shared mission of our two organizations: to empower dentists with best-in-class tools that improve patient outcomes,' said Justin Hunt, CEO of SimplyTest. 'Smile Source is known for its high standards and rigorous vendor vetting. We're honored to be selected as their exclusive salivary screening partner, offering members access to PERIO through their trusted membership platform.' This is the first salivary testing solution offered through Smile Source, underscoring the growing demand among private practitioners for integrated, preventive health solutions in dentistry. With PERIO, member dentists will be equipped to provide earlier, more precise care and expand their role in systemic health detection and personalized treatment. Periodontal disease doesn't just affect the mouth; it is a chronic, often silent condition with far-reaching consequences including strong links to Alzheimer's, diabetes, cardiovascular disease and cancer. PERIO helps dental professionals uncover what traditional exams may overlook. By detecting microbial risk factors early, clinicians can intervene sooner and educate patients more effectively to better support long-term health. 'We're thrilled to welcome SimplyTest Oral Health-PERIO to the Smile Source family,' said Tom Rimmer, Vice President of Strategic Partnerships at Smile Source. 'This partnership gives our members access to a science-backed, noninvasive testing tool, which many have been asking for to elevate patient care. PERIO represents a meaningful advancement in their clinical capabilities, and we're excited to see its positive impact across the network.' PERIO integrates advanced molecular testing into everyday dental workflows. A quick, pain-free saliva sample identifies key periodontal pathogens, caries-related organisms, Candida albicans and viruses associated with cognitive decline, cardiovascular disease and more. A patented buffer solution stabilizes samples at room temperature, making the test easy to implement and practical for busy practices. PERIO represents a shift toward smarter, evidence-based care. For Smile Source members, it not only enhances treatment outcomes at the chair, but also elevates their role as vital contributors to their patients' overall health. About Smile Source Smile Source is the leading network of independent dental practices in the United States, supporting more than 800 independently owned offices with the collective power to compete, grow and thrive. Through access to proven technology, innovative clinical solutions, and shared business resources, Smile Source empowers dentists to elevate patient care, enhance profitability and protect their independence. To learn more, visit About SimplyTest SimplyTest® is redefining the starting point of care through next-generation salivary science. The SimplyTest platform delivers fast, noninvasive screenings that empower health care providers, functional medicine practitioners and dental professionals to detect microbial risks earlier, personalize treatment with precision and connect oral health to whole-body outcomes. Built on the belief that better diagnostics lead to better outcomes, SimplyTest is advancing a smarter, data-driven model of dentistry where early insight is the first step in personalized care. To learn more, visit
Scottish Sun
29-05-2025
- Health
- Scottish Sun
Warning as deadly fungal infections that enter the bloodstream on the rise – and scientists identify those most at risk
'Our surveillance shows that serious fungal infections are having an increasing impact on public health,' Professor Andy Borman from the UKHSA says 'REMAIN VIGILANT' Warning as deadly fungal infections that enter the bloodstream on the rise – and scientists identify those most at risk Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) SEVERAL deadly fungal infections are on the rise in England, health chiefs warn - including one labeled a 'huge threat to humanity'. In 2024, cases of fungi entering the bloodstream rose slightly from 3.8 to 3.9 per 100,000 people, new figures from the UK Health Security Agency (UKHSA) reveal. Sign up for Scottish Sun newsletter Sign up 2 Experts think the rise in infections may be linked to more complex surgeries, longer hospital stays, and increased antibiotic use Credit: Getty Most were found in vulnerable patients in hospitals, particularly those with weakened immune systems. Bloodstream infections caused by a type of fungus called yeast usually happen in hospitals, from yeasts that naturally live on our skin or inside our bodies. The main culprits behind these new infections are yeast species like Candida albicans, Nakaseomyces glabratus, and Candida parapsilosis. Candida albicans, or C. albicans as it is sometimes called, has already been named by the World Health Organization (WHO) as one of 19 deadly fungi posing a serious threat to humanity. It's branded a superbug because it's becoming harder and harder to treat due to growing drug resistance. But UKHSA chiefs are most concerned about Candidozyma auris - a tougher, drug-resistant fungus that has also been reported and can be deadly and spreads easily in hospitals. Between 2013 and 2024, there were 637 reported cases of in England, with 178 just last year alone, data suggests. Once rare, it's been steadily rising, especially since the Covid pandemic restrictions ended. Experts say the rise may be linked to more complex surgeries, longer hospital stays, and increased antibiotic use – all of which can weaken the body's defenses. 'Our surveillance shows that serious fungal infections are having an increasing impact on public health," Professor Andy Borman from the UKHSA said. Are fungal infections a serious threat? "The rise of drug-resistant C. auris means we must remain vigilant to protect patient safety.' To tackle this threat, UKHSA has stepped up surveillance and made C. auris a notifiable infection. This means hospitals must report cases quickly to help control outbreaks. 2 The WHO have ranked 19 fungal priority pathogensbased on threat to humanity
Economic Times
07-05-2025
- Health
- Economic Times
Is there a new global health threat? Fungal superbugs spread panic with climate change expanding its reach
Another dangerous fungus causes lung issues WHO lists 19 fungal species as urgent priorities Live Events Climate change could exacerbate the spread Urgent need for antifungal innovation FAQs: (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel A new global health threat is emerging—drug-resistant fungal infections . These microscopic fungal spores like Coccidioides , responsible for valley fever , are infecting people who inhale them from air or soil, even in their own Irvin from California became critically ill after he unknowingly inhaled the spores. Doctors took nearly a year to correctly diagnose him. However, by that time, he had lost a significant amount of weight and nearly per a CNN report, another survivor Rob Purdie contracted fungal meningitis after he inhaled spores while gardening and now depends on lifelong toxic treatments. Aspergillus fumigatus , another dangerous fungus, could spread across Europe, Asia, and the Americas, and will affect millions of vulnerable individuals. This fungus, a study said, thrives in warm, damp environments and could potentially infect people by invading their lungs, particularly those who have underlying health issues like asthma, cystic fibrosis, or weakened immune World Health Organisation (WHO) reportedly has enlisted nearly 6.5 million invasive fungal infections. This, they said, results in 3.8 million deaths globally each year and the numbers are climbing due to increasing drug listed 19 fungal species under urgent priorities for new drug development, among which Aspergillus fumigatus is one. Other dangerous species include Cryptococcus neoformans (deadly meningitis), Candida auris (highly drug-resistant hospital infections) and Candida albicans (common yeast that can become invasive).The CNN report stated that developing antifungal drugs is especially challenging since fungi are genetically closer to humans than bacteria. This means, the treatments can harm human cells, which could result in kidney failure, liver damage, or other severe side Neil Clancy, an infectious disease specialist and associate professor of medicine at University of Pittsburgh, told CNN that if an antifungal drug is being made, it is crucial to come up with formulations that will not harm genes and human have noted that changing climate patterns, wildfires, and dust storms likely expand the fungi's geographic reach. Reportedly, cases of Coccidioides infection have been reported in over 20 US states, including regions which previously were study on Aspergillus fumigatus stated it could expand across an additional 77 per cent of global territory by 2100 as climate change is accelerated. Researchers have estimated that 9 million people in Europe alone could be exposed to infection risks if fungus takes the fungus can grow rapidly in compost at high temperatures and can survive the human body's internal heat of 37°C. It was also found thriving in extreme environments like Chernobyl's nuclear drugs like Olorofim offer hope, however, experts have warned that limited specialist access and lack of public awareness could leave many patients untreated or misdiagnosed. More research, better treatments, and physician training are urgently needed to confront this growing fungal superbug threat, stated the CNN Elaine Bignell, co-director at the MRC Centre for Medical Mycology at Exeter University, said that the development of new antifungal treatments has been slow. One key reason, as per an NDTV report, is financial unattractiveness of investing in antifungal the antifungal medicines are costly to develop and often spotted as less profitable compared to others in drug are fungal infections that no longer react to usual antifungal treatment, so they are more difficult to treat and are possibly includes species such as Aspergillus fumigatus, Candida auris, Cryptococcus neoformans, and Coccidioides among the most lethal ones.
